Portfolio (Quarterly)
Guide ↗
DC Funds, LP
· CIK 0001869028| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TCRX | TSCAN THERAPEUTICS INC | Healthcare | 630,000.0 | $630K | 42.40% | — | — | $1.00 | +0.0% |
| 2 | HOWL | WEREWOLF THERAPEUTICS INC | Healthcare | 589,102.0 | $490K | 33.01% | — | — | $0.83 | -38.1% |
| 3 | — | BARINTHUS BIOTHERAPEUTICS PL | — | 642,204.0 | $365K | 24.59% | — | — | $0.57 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%